Global CRM197 Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global CRM197 market size will reach 209.62 Million USD in 2025 and is projected to reach 307.77 Million USD by 2032, with a CAGR of 5.64% (2025-2032). Notably, the China CRM197 market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
CRM197 is a non-toxic mutant form of diphtheria toxin, a protein produced by the bacterium Corynebacterium diphtheriae. It is used in the development of certain vaccines as a carrier protein or conjugate. CRM197 lacks the toxic properties of the wild-type diphtheria toxin but retains its ability to bind to the same receptors on cells. This makes it a valuable component in conjugate vaccines, where it is chemically linked to a weak antigen to enhance the body's immune response. By linking CRM197 to a specific antigen from a disease-causing organism, the immune system recognizes both the antigen and the carrier protein, leading to a more robust and long-lasting immune response against the target pathogen. CRM197 has been used successfully in several vaccines, including vaccines against pneumococcal bacteria, Haemophilus influenzae type b, and meningococcal bacteria, helping to protect individuals against these infectious diseases.
The major global suppliers of CRM197 include Pfizer, Ligand Pharmaceuticals, CanSino Biologic, Beijing Kexing Biology Product, Scarab Genomics, Xpress Biologics, Fina Biosolutions, Eubiologics, EirGenix, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of CRM197. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global CRM197 market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the CRM197 market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CRM197 industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of CRM197 Include:
Pfizer
Ligand Pharmaceuticals
CanSino Biologic
Beijing Kexing Biology Product
Scarab Genomics
Xpress Biologics
Fina Biosolutions
Eubiologics
EirGenix
CRM197 Product Segment Include:
Research Grade CRM197
cGMP Grade CRM197
CRM197 Product Application Include:
Pneumococcal Conjugate Vaccine
Meningococcal Polysaccharide Conjugate Vaccine
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global CRM197 Industry PESTEL Analysis
Chapter 3: Global CRM197 Industry Porter's Five Forces Analysis
Chapter 4: Global CRM197 Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global CRM197 Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global CRM197 Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, CRM197 Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global CRM197 market size will reach 209.62 Million USD in 2025 and is projected to reach 307.77 Million USD by 2032, with a CAGR of 5.64% (2025-2032). Notably, the China CRM197 market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
CRM197 is a non-toxic mutant form of diphtheria toxin, a protein produced by the bacterium Corynebacterium diphtheriae. It is used in the development of certain vaccines as a carrier protein or conjugate. CRM197 lacks the toxic properties of the wild-type diphtheria toxin but retains its ability to bind to the same receptors on cells. This makes it a valuable component in conjugate vaccines, where it is chemically linked to a weak antigen to enhance the body's immune response. By linking CRM197 to a specific antigen from a disease-causing organism, the immune system recognizes both the antigen and the carrier protein, leading to a more robust and long-lasting immune response against the target pathogen. CRM197 has been used successfully in several vaccines, including vaccines against pneumococcal bacteria, Haemophilus influenzae type b, and meningococcal bacteria, helping to protect individuals against these infectious diseases.
The major global suppliers of CRM197 include Pfizer, Ligand Pharmaceuticals, CanSino Biologic, Beijing Kexing Biology Product, Scarab Genomics, Xpress Biologics, Fina Biosolutions, Eubiologics, EirGenix, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of CRM197. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global CRM197 market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the CRM197 market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CRM197 industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of CRM197 Include:
Pfizer
Ligand Pharmaceuticals
CanSino Biologic
Beijing Kexing Biology Product
Scarab Genomics
Xpress Biologics
Fina Biosolutions
Eubiologics
EirGenix
CRM197 Product Segment Include:
Research Grade CRM197
cGMP Grade CRM197
CRM197 Product Application Include:
Pneumococcal Conjugate Vaccine
Meningococcal Polysaccharide Conjugate Vaccine
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global CRM197 Industry PESTEL Analysis
Chapter 3: Global CRM197 Industry Porter's Five Forces Analysis
Chapter 4: Global CRM197 Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global CRM197 Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global CRM197 Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, CRM197 Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 CRM197 Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 CRM197 Product by Type
- 1.2.1 Research Grade CRM197
- 1.2.2 cGMP Grade CRM197
- 1.3 CRM197 Product by Application
- 1.3.1 Pneumococcal Conjugate Vaccine
- 1.3.2 Meningococcal Polysaccharide Conjugate Vaccine
- 1.3.3 Others
- 1.4 Global CRM197 Market Size Analysis (2020-2032)
- 1.5 CRM197 Market Development Status and Trends
- 1.5.1 CRM197 Industry Development Status Analysis
- 1.5.2 CRM197 Industry Development Trends Analysis
- 2 CRM197 Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 CRM197 Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global CRM197 Market Analysis by Country
- 4.1 Global CRM197 Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global CRM197 Revenue Analysis by Country (2020-2025)
- 4.1.2 Global CRM197 Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.5 China CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.6 France CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.14 India CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand CRM197 Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa CRM197 Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global CRM197 Market Revenue by Key Suppliers (2021-2025)
- 5.2 CRM197 Competitive Landscape Analysis and Market Dynamic
- 5.2.1 CRM197 Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 CRM197 Market Analysis by Type
- 6.1 Global CRM197 Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global CRM197 Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Pfizer
- 7.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Pfizer CRM197 Product Portfolio
- 7.1.3 Pfizer CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Ligand Pharmaceuticals
- 7.2.1 Ligand Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Ligand Pharmaceuticals CRM197 Product Portfolio
- 7.2.3 Ligand Pharmaceuticals CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 CanSino Biologic
- 7.3.1 CanSino Biologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 CanSino Biologic CRM197 Product Portfolio
- 7.3.3 CanSino Biologic CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Beijing Kexing Biology Product
- 7.4.1 Beijing Kexing Biology Product Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Beijing Kexing Biology Product CRM197 Product Portfolio
- 7.4.3 Beijing Kexing Biology Product CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Scarab Genomics
- 7.5.1 Scarab Genomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Scarab Genomics CRM197 Product Portfolio
- 7.5.3 Scarab Genomics CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Xpress Biologics
- 7.6.1 Xpress Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Xpress Biologics CRM197 Product Portfolio
- 7.6.3 Xpress Biologics CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Fina Biosolutions
- 7.7.1 Fina Biosolutions Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Fina Biosolutions CRM197 Product Portfolio
- 7.7.3 Fina Biosolutions CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Eubiologics
- 7.8.1 Eubiologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Eubiologics CRM197 Product Portfolio
- 7.8.3 Eubiologics CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 EirGenix
- 7.9.1 EirGenix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 EirGenix CRM197 Product Portfolio
- 7.9.3 EirGenix CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 CRM197 Industry Chain Analysis
- 8.2 CRM197 Product Downstream Application Analysis
- 8.2.1 Global CRM197 Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global CRM197 Revenue and Forecast by Application (2020-2032)
- 8.3 CRM197 Typical Downstream Customers
- 8.4 CRM197 Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
